Oxford Laboratories Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Oxford Laboratories Private Limited Pharmaceutical Export Portfolio Dataset — 4 Products, $3.0M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Oxford Laboratories Private Limited — Pharmaceutical Exporter Profile (2026) | 4 Products, $3.0M Trade | TransData Nexus

Who is Oxford Laboratories Private Limited? — Company Overview & Market Position

Oxford Laboratories Private Limited, established on January 31, 2000, is a privately held pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24230MH2000PTC123927. As of the latest available data, Oxford Laboratories has an authorized capital of ₹2.50 crore and a paid-up capital of ₹1.50 crore. The company employs approximately 89 professionals across various functions.

Oxford Laboratories specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's product portfolio spans multiple therapeutic categories, with a significant focus on antifungals, antibiotics, and antimalarial & antiparasitic agents. In the fiscal year ending March 31, 2024, Oxford Laboratories reported a substantial 18.9% increase in revenue and a 39.62% rise in profit, indicating robust financial health and operational efficiency.

What Does Oxford Laboratories Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Clotrimazole$1.2M 2Gentamicin$1.1M 3Pyrantel$539.4K 4Omega$134.0K

Oxford Laboratories Private Limited Therapeutic Categories — 4 Specializations

Oxford Laboratories Private Limited operates across 4 therapeutic categories, with Antifungals (41.1%), Antibiotics (36.6%), Antimalarial & Antiparasitic (17.9%) representing the largest segments by export value. The portfolio is concentrated — the top 5 products account for 100% of total exports.

Antifungals

1 products · 41.1% · $1.2M

Antibiotics

1 products · 36.6% · $1.1M

Antimalarial & Antiparasitic

1 products · 17.9% · $539.4K

Nutritional Supplements

1 products · 4.4% · $134.0K

Product Portfolio — Top 4 by Export Value

Oxford Laboratories Private Limited exports 4 pharmaceutical products across 4 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Clotrimazole	Antifungals	$1.2M	42	1.3%

Key Metrics

Total Trade$3.0M

Products4

Shipments114

Categories4

#1 Rankings0

Top 5 Concentration100.0%

Top Categories

Antifungals41.1%

Antibiotics36.6%

Antimalarial & Antiparasitic17.9%

Last updated: March 28, 2026

Oxford Laboratories Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Oxford Laboratories operates a state-of-the-art manufacturing plant located in Pardi, Gujarat. This facility is equipped to produce a diverse range of pharmaceutical formulations, including tablets, capsules, external preparations (creams, ointments, gels), liquid orals, injections (both small volume parenterals and large volume parenterals), nutraceuticals, and herbal Ayurvedic and cosmetic products. The plant adheres to stringent quality control measures and is accredited with WHO-GMP and ISO 9001:2015 certifications, underscoring its commitment to producing high-quality pharmaceutical products.

Oxford Laboratories Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Oxford Laboratories' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. However, the company's WHO-GMP certification suggests adherence to international manufacturing standards, which is a critical component for FDA approvals. To obtain precise information on FDA approvals and inspections, direct communication with the company or the FDA would be necessary.

2WHO & EU GMP

Oxford Laboratories' manufacturing facility in Gujarat holds WHO-GMP certification, indicating compliance with the World Health Organization's Good Manufacturing Practices. This certification is essential for exporting pharmaceutical products to various international markets, including the European Union. While specific EU GMP certificates or EDQM status are not detailed in the available sources, the WHO-GMP certification serves as a foundational requirement for market access in the EU.

3CDSCO & Indian Regulatory

Oxford Laboratories holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority in India. The company's manufacturing facility in Gujarat is approved by the CDSCO, ensuring compliance with national standards for pharmaceutical manufacturing. Additionally, the company has obtained export No Objection Certificates (NOCs) from the Directorate General of Foreign Trade (DGFT), facilitating its export operations.

4Recent Regulatory Actions

As of the latest available information, there are no publicly disclosed Form 483 observations, warning letters, or import alerts associated with Oxford Laboratories. The company's adherence to WHO-GMP and ISO 9001:2015 standards reflects its commitment to maintaining high-quality manufacturing practices and regulatory compliance.

TransData Nexus Research · FDA Orange Book, WHO PQ database, EMA GMP registry, CDSCOMar 2026

Buyer Due Diligence Brief — Evaluating Oxford Laboratories Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Oxford Laboratories has demonstrated a consistent track record in pharmaceutical manufacturing, with a total export value of $3.0 million USD and 114 shipments across four therapeutic categories. The company's portfolio concentration, with the top five products accounting for 100% of exports, indicates a focused approach to product development and market strategy. The company's adherence to WHO-GMP and ISO 9001:2015 standards further underscores its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

WHO-GMP Certification: Confirms adherence to the World Health Organization's Good Manufacturing Practices. Verification can be done by contacting the company directly or through the WHO's official channels.

ISO 9001:2015 Certification: Indicates compliance with international quality management standards. Verification can be conducted by contacting the company or through the International Organization for Standardization's official website.

3Due Diligence Checklist

Importers should undertake the following steps to ensure a thorough evaluation of Oxford Laboratories:

Verify Certifications: Confirm the validity of WHO-GMP and ISO 9001:2015 certifications through official channels.

Assess Financial Health: Review the company's financial statements for the latest fiscal year to evaluate profitability and operational efficiency.

Evaluate Product Portfolio: Analyze the company's product offerings to ensure alignment with market demands and quality standards.

Check Regulatory Compliance: Ensure the company holds necessary manufacturing licenses and export No Objection Certificates (NOCs) from relevant authorities.

Review Market Presence: Assess the company's presence in target markets to gauge reliability and market acceptance.

By conducting this due diligence, importers can make informed decisions regarding partnerships with Oxford Laboratories.

TransData Nexus Research · FDA, WHO, EMA regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Supplier Matching: Oxford Laboratories Private Limited identified across shipments using name normalization.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
3.Market Share: Calculated per product as Oxford Laboratories Private Limited's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 114 individual customs records matching Oxford Laboratories Private Limited.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

4 Products Tracked

4 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Oxford Laboratories Private Limited

Oxford Laboratories Private Limited — Export Portfolio & Destination Treemap

Who is Oxford Laboratories Private Limited? — Company Overview & Market Position

What Does Oxford Laboratories Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

Oxford Laboratories Private Limited Therapeutic Categories — 4 Specializations

Product Portfolio — Top 4 by Export Value

Key Metrics

Top Categories

Oxford Laboratories Private Limited — Corporate Profile & Information

1Corporate Overview

2Manufacturing Facilities

Top Export Routes

Related Analysis

Need Detailed Data?

3Key Leadership

Where Does Oxford Laboratories Private Limited Export? — Destination Intelligence

1Regulated Markets

2Emerging Markets

3Geographic Strategy

Oxford Laboratories Private Limited — Manufacturing & Regulatory Profile

1FDA Status

2WHO & EU GMP

3CDSCO & Indian Regulatory

4Recent Regulatory Actions

Oxford Laboratories Private Limited — Competitive Positioning Among Indian Pharma Exporters

1Competitive Landscape

2Key Differentiators

3Strategic Position

Buyer Due Diligence Brief — Evaluating Oxford Laboratories Private Limited as a Supplier

1Supplier Assessment

2Certifications to Verify

3Due Diligence Checklist

Frequently Asked Questions — Oxford Laboratories Private Limited

How many pharmaceutical products does Oxford Laboratories Private Limited export from India?

What is Oxford Laboratories Private Limited's total pharmaceutical export value?

What therapeutic categories does Oxford Laboratories Private Limited cover?

Get Full Oxford Laboratories Private Limited Export Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology